{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T04:22:31Z","timestamp":1783743751335,"version":"3.55.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,8,9]],"date-time":"2013-08-09T00:00:00Z","timestamp":1376006400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s13730-013-0088-8","type":"journal-article","created":{"date-parts":[[2013,8,8]],"date-time":"2013-08-08T11:43:45Z","timestamp":1375962225000},"page":"68-74","source":"Crossref","is-referenced-by-count":11,"title":["Renal cell carcinoma presenting as AA amyloidosis: a case report and review of the literature"],"prefix":"10.1007","volume":"3","author":[{"given":"Adarsh","family":"Babu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Pickett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preetham","family":"Boddana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linmarie","family":"Ludeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,9]]},"reference":[{"key":"88_CR1","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1056\/NEJMoa070265","volume":"356","author":"HJ Lachmann","year":"2007","unstructured":"Lachmann HJ, Goodman HJ, Gilbertson JA, et al. Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007;356:2361\u201371.","journal-title":"N Engl J Med"},{"key":"88_CR2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/0002-9343(82)90747-1","volume":"73","author":"M Pras","year":"1982","unstructured":"Pras M, Franklin EC, Shibolet S, Frangione B. Amyloidosis associated with renal cell carcinoma of the AA type. Am J Med. 1982;73:426\u20138. PMID 7124769.","journal-title":"Am J Med"},{"key":"88_CR3","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/ndt\/16.7.1517","volume":"16","author":"H Jaakkola","year":"2001","unstructured":"Jaakkola H, T\u00f6rnroth T, Groop PH, Honkanen E. Renal failure and nephrotic syndrome associated with gastrointestinal stromal tumour (GIST)\u2014a rare cause of AA amyloidosis. Nephrol Dial Transplant. 2001;16:1517\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"88_CR4","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1053\/ajkd.2002.34545","volume":"40","author":"I Agha","year":"2002","unstructured":"Agha I, Mahoney R, Beardslee M, Liapis H, Cowart RG, Juknevicius I. Systemic amyloidosis associated with pleomorphic sarcoma of the spleen and remission of nephrotic syndrome after removal of the tumor. Am J Kidney Dis. 2002;40:411\u201341.","journal-title":"Am J Kidney Dis"},{"issue":"14S","key":"88_CR5","doi-asserted-by":"crossref","first-page":"9711","DOI":"10.1200\/jco.2004.22.14_suppl.9711","volume":"22","author":"M Mata","year":"2004","unstructured":"Mata M, Lohr T, Lakshminarayanan M, Lo KH, Prabhakar U. Centocor, Inc., Malvern, PA. Serum amyloid A (SAA), C-reactive protein (CRP) and IL-6 as prognostic indicators in renal cell carcinoma and prostate cancer. J Clin Oncol. 2004;22(14S):9711.","journal-title":"J Clin Oncol"},{"issue":"1","key":"88_CR6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/sj.bjc.6605720","volume":"103","author":"SL Wood","year":"2010","unstructured":"Wood SL, Rogers M, Cairns DA, Paul A, Thompson D, Vasudev NS, et al. Association of serum amyloid A protein and peptide fragments with prognosis in renal cancer. Br J Cancer. 2010;103(1):101\u201311. Epub 2010 Jun 8.","journal-title":"Br J Cancer"},{"key":"88_CR7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/0002-9343(57)90129-8","volume":"22","author":"L Berger","year":"1957","unstructured":"Berger L, Sinkoff MW. Systemic manifestations of hypernephroma review of 273 cases. Am J Med. 1957;22:791\u20136.","journal-title":"Am J Med"},{"issue":"6","key":"88_CR8","first-page":"411","volume":"89","author":"M Dictor","year":"1981","unstructured":"Dictor M, Hasserius R. Systemic amyloidosis and non-hematologic malignancy in a large autopsy series. Acta Pathol Microbiol Scand A. 1981;89(6):411\u20136.","journal-title":"Acta Pathol Microbiol Scand A"},{"key":"88_CR9","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1084\/jem.148.4.1020","volume":"148","author":"G Lavie","year":"1978","unstructured":"Lavie G, Zucker-Franklin D, Franklin EC. Degradation of serum amyloid A protein by surface-associated enzymes of human blood monocytes. J Exp Med. 1978;418:1020\u201331.","journal-title":"J Exp Med"},{"issue":"2","key":"88_CR10","first-page":"377","volume":"137","author":"GT Westermark","year":"1990","unstructured":"Westermark GT, Sletten K, Grubb A, Westermark P. AA-amyloidosis. Tissue component-specific association of various protein AA subspecies and evidence of a fourth SAA gene product. Am J Pathol. 1990;137(2):377\u201383. PMID 2386201.","journal-title":"Am J Pathol"},{"issue":"6","key":"88_CR11","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/jcp.19.6.539","volume":"19","author":"JG Azzopardi","year":"1966","unstructured":"Azzopardi JG, Lehner T. Systemic amyloidosis and malignant disease. J Clin Pathol. 1966;19(6):539\u201348.","journal-title":"J Clin Pathol"},{"key":"88_CR12","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0014-5793(89)80805-1","volume":"250","author":"S Miki","year":"1989","unstructured":"Miki S, Iwano M, Miki Y, et al. Interleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett. 1989;250:607\u201310.","journal-title":"FEBS Lett"},{"key":"88_CR13","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/sj.bjc.6605872","volume":"103","author":"J-F Rossi","year":"2010","unstructured":"Rossi J-F, N\u00e9grier S, James ND, et al. A phase I\/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer. Br J Cancer. 2010;103:1154\u201362. doi: 10.1038\/sj.bjc.6605872 .","journal-title":"Br J Cancer"},{"key":"88_CR14","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00005792-199107000-00002","volume":"70","author":"MA Gertz","year":"1991","unstructured":"Gertz MA, Kyle RA. Secondary systemic amyloidosis: response and survival in 64 patients. Medicine (Baltimore). 1991;70:246\u201356.","journal-title":"Medicine (Baltimore)"},{"key":"88_CR15","first-page":"343","volume":"21","author":"F Tanaka","year":"2003","unstructured":"Tanaka F, Migita K, Honda S, et al. Clinical outcome and survival of secondary (AA) amyloidosis. Clin Exp Rheumatol. 2003;21:343.","journal-title":"Clin Exp Rheumatol"},{"key":"88_CR16","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1136\/bmj.286.6375.1391","volume":"286","author":"HM Falck","year":"1983","unstructured":"Falck HM, Maury CP, Teppo AM, Wegelius O. Correlation of persistently high serum amyloid A protein and C-reactive protein concentrations with rapid progression of secondary amyloidosis. Br Med J (Clin Res Ed). 1983;286:1391.","journal-title":"Br Med J (Clin Res Ed)"},{"key":"88_CR17","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/S0016-5085(97)70150-1","volume":"112","author":"LB Lovat","year":"1997","unstructured":"Lovat LB, Madhoo S, Pepys MB, Hawkins PN. Long-term survival in systemic amyloid A amyloidosis complicating Crohn\u2019s disease. Gastroenterology. 1997;112:1362\u20135.","journal-title":"Gastroenterology"},{"key":"88_CR18","first-page":"479","volume":"63","author":"H Waldenstr\u00f6m","year":"1928","unstructured":"Waldenstr\u00f6m H. On the formation and disappearance of amyloid in man. Acta Chir Scand. 1928;63:479\u2013530.","journal-title":"Acta Chir Scand"},{"key":"88_CR19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1080\/13506120600876930","volume":"13","author":"Y Shimojima","year":"2006","unstructured":"Shimojima Y, Takei Y, Tazawa K, et al. Histopathological regression of systemic AA amyloidosis after surgical treatment of a localized Castleman\u2019s disease. Amyloid. 2006;13:184\u20136.","journal-title":"Amyloid"},{"key":"88_CR20","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/rheumatology\/41.7.833","volume":"41","author":"V Ortiz-Santamar\u00eda","year":"2002","unstructured":"Ortiz-Santamar\u00eda V, Oliv\u00e9 A, Valls-Roc M, Tena X. Treatment of AA amyloid with chlorambucil. Rheumatology (Oxford). 2002;41:833.","journal-title":"Rheumatology (Oxford)"},{"key":"88_CR21","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10067-003-0763-9","volume":"22","author":"T Nakamura","year":"2003","unstructured":"Nakamura T, Yamamura Y, Tomoda K, Tsukano M, Shono M, Baba S. Efficacy of cyclophosphamide combined with prednisolone in patients with AA amyloidosis secondary to rheumatoid arthritis. Clin Rheumatol. 2003;22:371\u20135.","journal-title":"Clin Rheumatol"},{"key":"88_CR22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/rheumatology\/keg101","volume":"42","author":"S Mpofu","year":"2003","unstructured":"Mpofu S, Teh LS, Smith PJ, Moots RJ, Hawkins PN. Cytostatic therapy for AA amyloidosis complicating psoriatic spondyloarthropathy. Rheumatology (Oxford). 2003;42:362\u20136.","journal-title":"Rheumatology (Oxford)"},{"key":"88_CR23","first-page":"2051","volume":"20","author":"K Berglund","year":"1993","unstructured":"Berglund K, Thysell H, Keller C. Results, principles and pitfalls in the management of renal AA-amyloidosis; a 10\u201321\u00a0year followup of 16 patients with rheumatic disease treated with alkylating cytostatics. J Rheumatol. 1993;20:2051\u20137.","journal-title":"J Rheumatol"},{"issue":"8","key":"88_CR24","first-page":"1482","volume":"33","author":"H Uda","year":"2006","unstructured":"Uda H, Yokota A, Kobayashi K, et al. Two distinct clinical courses of renal involvement in rheumatoid patients with AA amyloidosis. J Rheumatol. 2006;33(8):1482\u20137. PMID 16881107.","journal-title":"J Rheumatol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-013-0088-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-013-0088-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-013-0088-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,20]],"date-time":"2019-07-20T13:16:25Z","timestamp":1563628585000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-013-0088-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,9]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["88"],"URL":"https:\/\/doi.org\/10.1007\/s13730-013-0088-8","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,9]]}}}